sabs stock price


The Wall Street analyst predicted that Sab Biotherapeutics's share price could reach $ by Nov 14, The average Sab Biotherapeutics stock price. SAB Biotherapeutics, Inc. ( Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock SAB Biotherapeutics. In , SABS's revenue was $ million, a decrease of % compared to the previous year's $ million. Losses were -$ million, % more than. SABS Stock Performance ; Day range, - 6 ; Year range, 3 - 14 ; Market cap, 55,, ; Primary exchange, NASDAQ. The SAB Biotherapeutics Inc stock price today is What Is the Stock Symbol for SAB Biotherapeutics Inc? The stock symbol for SAB Biotherapeutics Inc is ".

SABS SAB Biotherapeutics · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. K · Turnover Ratio. % · P/E (Static). SAB Biotherapeutics Inc. SABS:US ; As of AM EST. ; Overview. OPEN. PREV. CLOSE. VOLUME. 10, MARKET CAP. M · DAY RANGE. – SAB Biotherapeutics Inc SABS:NASDAQ ; Last | 03/08/24 EDT. quote price arrow up + (+%) ; Volume. 13, ; 52 week range. - Stock Price Forecast. The 2 analysts with month price forecasts for SAB Biotherapeutics stock have an average target of 20, with a low estimate of 10 and a. View SAB Biotherapeutics, Inc. SABS stock quote prices, financial information, real-time forecasts, and company news from CNN. SABS support price is $ and resistance is $ (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility. Discover real-time Brunello Cucinelli S.p.A. (SABS) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since it has more than doubled. SABS SAB Biotherapeutics Inc. 1, $ $ (%). Today. Market Cap, $M. Wk High, $ Wk Low, $ ST Data. Watchers. Price Performance ; 3-Month. +%. on 01/29/ Period Open: %. on 11/30/ (%). since 11/16/23 ; Week. +%. on.

SAB Biotherapeutics Inc. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. m ; Total Shares. m. SABS | Complete SAB Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Based on 1 Wall Street analysts offering 12 month price targets for SAB Biotherapeutics in the last 3 months. The average price target is $ with a high. SAB Biotherapeutics Inc. ; Open $ ; Day Range - ; 52 Week Range - ; Market Cap $M ; Public Float M. Discover historical prices for SABS stock on Yahoo Finance. View daily, weekly or monthly format back to when SAB Biotherapeutics, Inc. stock was issued. SABS Stock Performance ; Day range, - ; Year range, 3 - 14 ; Market cap, 53,, ; Primary exchange, NASDAQ. Stock Quote & Chart. Stock Quote. NASDAQ: SABS. $ Mar 8, PM EST. Change. + (+%). Volume. 13, Today's Open. $ Previous Close. SAB Biotherapeutics Inc. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - SAB Biotherapeutics (SABS) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom.

Low, $ ; Average, $ ; Current Price, $ ; Q4 Q1 Q2 Q3 ; Estimate View the latest SAB Biotherapeutics Inc. (SABS) stock price, news, historical charts, analyst ratings and financial information from WSJ. The week high price of SAB Biotherapeutics Inc (SABS) is The week low price of SAB Biotherapeutics Inc (SABS) is Research SAB Biotherapeutics' (Nasdaq:SABS) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Historical daily share price chart and data for SAB Biotherapeutics since adjusted for splits and dividends. The latest closing stock price for SAB.

SAB Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SABS updated stock price target summary.

price of algo | ethermineorg

15 16 17 18 19

Copyright 2017-2024 Privice Policy Contacts SiteMap RSS